EG-VEGF maternal levels predict spontaneous preterm birth in the second and third trimesters in pregnant women with risk factors for placenta-mediated complications

Sci Rep. 2023 Nov 14;13(1):19921. doi: 10.1038/s41598-023-46883-6.

Abstract

Prediction of spontaneous preterm birth in asymptomatic women remains a great challenge for the public health system. The aim of the study was to determine the informational value of EG-VEGF circulating levels for prediction of spontaneous preterm birth in the second and third trimesters in pregnant women at high risk for placenta-mediated complications. A prospective multicenter cohort study including 200 pregnant patients with five-serum sampling per patient. Women with spontaneous preterm birth have higher concentrations of serum EG-VEGF than uncomplicated patients at 24 weeks, 28 weeks and 32 weeks (p = 0.03, 0.02 and < 0.001). The areas under the curve reached 0.9 with 100% sensitivity at 32 weeks for the prediction of spontaneous preterm birth. Serum EG-VEGF concentrations could be considered as a reliable biomarker of spontaneous preterm birth in high-risk for placenta-mediated complications pregnant women.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Female
  • Humans
  • Infant, Newborn
  • Placenta
  • Pregnancy
  • Pregnancy Trimester, Third
  • Pregnant Women
  • Premature Birth*
  • Prospective Studies
  • Risk Factors
  • Vascular Endothelial Growth Factor, Endocrine-Gland-Derived*

Substances

  • Vascular Endothelial Growth Factor, Endocrine-Gland-Derived